Hyperfine (NASDAQ:HYPR – Get Free Report) is expected to issue its Q2 2025 quarterly earnings data after the market closes on Wednesday, August 13th. Analysts expect Hyperfine to post earnings of ($0.12) per share and revenue of $3.00 million for the quarter.
Hyperfine (NASDAQ:HYPR – Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported ($0.12) EPS for the quarter, meeting analysts’ consensus estimates of ($0.12). The firm had revenue of $2.14 million for the quarter, compared to the consensus estimate of $2.82 million. Hyperfine had a negative net margin of 343.42% and a negative return on equity of 74.19%. On average, analysts expect Hyperfine to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Hyperfine Stock Performance
HYPR opened at $1.30 on Tuesday. The company has a market capitalization of $101.18 million, a P/E ratio of -2.41 and a beta of 1.06. The company has a 50-day moving average of $0.88 and a 200-day moving average of $0.87. Hyperfine has a 1-year low of $0.53 and a 1-year high of $1.90.
Wall Street Analyst Weigh In
Read Our Latest Report on HYPR
Hyperfine Company Profile
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
Featured Stories
- Five stocks we like better than Hyperfine
- Russell 2000 Index, How Investors Use it For Profitable Trading
- MNDY Stock Has a Case of the Mondays—Buy Before the Rebound
- What is a Dividend King?
- IPO Market Stays Hot With These 2 Debuting Stocks
- Trading Stocks: RSI and Why it’s Useful
- Taiwan Semiconductor Stock: Own It, Don’t Trade It
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.